retatrutide not losing weight for loss: Study shows 30% body weight loss Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Kidney Protection and Brain Health A trial found semaglutide reduced kidney events by 24% in people with type 2 diabetes and chronic kidney disease using a lower dose, not the maximum. GLP-1s also strengthen the blood-brain barrier and enhance neuron survival, with early data hinting at benefits for cognitive decline and Alzheimer's disease. Systemic Anti-Inflammatory Effects GLP-1s reduce systemic inflammation throughout the body. This benefit doesn't get talked about much, though inflammation drives almost every chronic disease

Its important to know that over-the-counter (OTC) dietary supplements are not reviewed or approved by the FDA

Bedrosian advocates that anyone considering these medications also make the necessary lifestyle changes and seek nutritional counseling and psychological support

How GLP-1 Meds Can Affect ADHD Meds Stimulants (Adderall, Vyvanse, Ritalin, Concerta, etc.) Appetite: You may notice even stronger appetite suppression

Combination GLP-1 Therapy: In some cases, combination approaches may be considered to support different aspects of health, depending on individual needs

Body weight and adiposity models: In diet-induced obesity (DIO) mouse models, retatrutide demonstrated pronounced effects on body weight trajectories over multi-week observation periods compared with vehicle controls